Evidence map›Paper›PMID 29297621›Full record

ArticleStem cells translational medicine2018

Amnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair.

Jean L Tan, Sin N Lau, Bryan Leaw, Hong P T Nguyen, Lois A Salamonsen, Mohamed I Saad, Siow T Chan, Dandan Zhu, Mirja Krause, Carla Kim and 3 more

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed, 1 pooled it
19.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 1 synthesis or guideline pooled it, 209 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Extracellular vesicle-mediated mechanisms and therapeutic potential in acute lung injury.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Macrophages and Pulmonary Fibrosis.Current molecular medicine · 2025
    Review
  17. Review
  18. Review
  19. Article
  20. Article

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Jean L TanThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.ORCID 0000-0001-9672-2531
Sin N LauThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Bryan LeawThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Hong P T NguyenCentre for Reproductive Health, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Lois A SalamonsenCentre for Reproductive Health, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Mohamed I SaadThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.ORCID 0000-0002-4855-2360
Siow T ChanThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Dandan ZhuThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Mirja KrauseThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Carla KimStem Cell Program, Children's Hospital Boston, Boston, Massachusetts, USA.
William SievertCentre for Inflammatory Disease, Monash University, Clayton, Victoria, Australia.
Euan M WallaceThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Rebecca LimThe Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.ORCID 0000-0002-0410-497X
Hudson Institute of Medical Research · AUMonash University · AUBoston Children's Hospital · USMonash Medical Centre · AU

Funding

Signaling pathways in lung stem cell differentiationR01HL125821 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI KIM, CARLA F. · 2015 to 2018
$1.8M
Mechanisms of Thrombospondin-1 as a pulmonary vascular mediatorR01HL132266 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI KIM, CARLA F. · 2017 to 2020
$1.6M
NHLBI NIH HHS R01 HL125821NHLBI NIH HHS R01 HL132266
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is characterized by chronic inflammation, severe scarring, and stem cell senescence. Stem cell-based therapies modulate inflammatory and fibrogenic pathways by release of soluble factors. Stem cell-derived extracellular vesicles should be explored as a potential therapy for IPF. Human amnion epithelial cell-derived exosomes (hAEC Exo) were isolated and compared against human lung fibroblasts exosomes. hAEC Exo were assessed as a potential therapy for lung fibrosis. Exosomes were isolated and evaluated for their protein and miRNA cargo. Direct effects of hAEC Exo on immune cell function, including macrophage polarization, phagocytosis, neutrophil myeloperoxidase activity and T cell proliferation and uptake, were measured. Their impact on immune response, histological outcomes, and bronchioalveolar stem cell (BASC) response was assessed in vivo following bleomycin challenge in young and aged mice. hAEC Exo carry protein cargo enriched for MAPK signaling pathways, apoptotic and developmental biology pathways and miRNA enriched for PI3K-Akt, Ras, Hippo, TGFβ, and focal adhesion pathways. hAEC Exo polarized and increased macrophage phagocytosis, reduced neutrophil myeloperoxidases, and suppressed T cell proliferation directly. Intranasal instillation of 10 μg hAEC Exo 1 day following bleomycin challenge reduced lung inflammation, while treatment at day 7 improved tissue-to-airspace ratio and reduced fibrosis. Administration of hAEC Exo coincided with the proliferation of BASC. These effects were reproducible in bleomycin-challenged aged mice. The paracrine effects of hAECs can be largely attributed to their exosomes and exploitation of hAEC Exo as a therapy for IPF should be explored further. Stem Cells Translational Medicine 2018;7:180-196.

Indexed as

AmnionAnimalsCell ProliferationCells, CulturedEpithelial CellsExosomesFemaleFibroblastsHumansLungLung InjuryMiceMice, Inbred C57BLNeutrophilsPneumoniaPregnancyFetal stem cellsLungProgenitor cellsTissue-specific stem cells

Identifiers

PMID29297621
PMCPMC5788876
OpenAlexW2781628997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.